Integral Diagnostics (ASX:IDX) Acquisition of Capitol Health Approved
Integral Diagnostics secures ACCC approval for Capitol Health acquisition, requiring divestiture of a clinic in the Melton region.
Integral Diagnostics secures ACCC approval for Capitol Health acquisition, requiring divestiture of a clinic in the Melton region.
Anteris Technologies Ltd (ASX: AVR) launches a U.S. IPO for 14.8 million shares to advance its innovative medical solutions.
TechGen Metals Limited enters an option agreement for an 80% stake in the Blue Bore Copper Project, showcasing significant discovery potential.
Godolphin Resources (ASX: GRL) successfully produces MREC-2, advancing the Narraburra Project and preparing for future industry engagements.
LTR Pharma Limited secures A$25 million to advance its SPONTAN® treatment through regulatory processes in the U.S. market.
Visioneering Technologies, Inc. (ASX:VTI) has announced its intent to voluntarily delist from the ASX, seeking shareholder approval for the move.
29Metals Limited (ASX:29M) launches a retail entitlement offer aiming to raise approximately $36.2 million as part of a $180 million capital raise.
Transurban Group (ASX:TCL) declares a 32.0-cent distribution and reaffirms its FY25 guidance amidst notable traffic growth.
Develop Global Limited finalises a loan facility with Trafigura and is progressing towards the re-start of the Woodlawn Copper-Zinc Mine.
Terrain Minerals Limited has commenced drilling at its Wildflower Gold Project, aiming to explore newly identified mineral zones.